INCENTIVE STOCK OPTION GRANT AGREEMENT CELLDEX THERAPEUTICS, INC.Incentive Stock Option Grant Agreement • June 17th, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledJune 17th, 2021 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Celldex Therapeutics, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENT CELLDEX THERAPEUTICS, INC.Nonqualified Stock Option Grant Agreement • June 17th, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledJune 17th, 2021 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Celldex Therapeutics, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
RESTRICTED STOCK AWARD AGREEMENT CELLDEX THERAPEUTICS, INC.Restricted Stock Award Agreement • June 17th, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledJune 17th, 2021 Company Industry JurisdictionThis Restricted Stock Award Agreement (the “Agreement”), dated as of the “Award Date” set forth in the attached Exhibit A (the “Award Date”), is entered into between Celldex Therapeutics, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Awardee”).
RESTRICTED STOCK UNIT AWARD AGREEMENT CELLDEX THERAPEUTICS, INC.Restricted Stock Unit Award Agreement • June 17th, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledJune 17th, 2021 Company Industry JurisdictionThis Restricted Stock Unit Award Agreement (the “Agreement” or “Award Agreement”), dated as of the “Award Date” set forth in the attached Exhibit A, is entered into between Celldex Therapeutics, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Awardee”).